Earlier initiation of dual therapy, cardiorenal protection new targets of T2DM management

01 Jun 2024
Earlier initiation of dual therapy, cardiorenal
protection new targets of T2DM management
Notable speakers Datuk Dr Akmal Arshad, Consultant Cardiologist, Gleneagles Hospital Kuala Lumpur, and Assoc. Prof Jeyakantha Ratnasingam, Senior Consultant Endocrinologist and Head of the Endocrine Division, University Malaya Medical Centre and University Malaya Specialist Centre, delve into the importance of early intervention and control of risk factors in managing these interrelated conditions.
Sponsored as an educational program by Boehringer Ingelheim (Malaysia) Sdn Bhd

Related MIMS Drugs

Resources

MY-BOE-128

MY-BOE-128

MY-BOE-128

MY-BOE-128